Edtech Market size to grow by USD 108.98 from 2022 to 2027 | The market is fragmented due to the presence of prominent companies like 2U Inc., Alphabet Inc., and Anthology Inc., many more

NEW YORK, Dec. 17, 2023 /PRNewswire/ — The Edtech Market is estimated to increase at a CAGR of 13.61% during the forecast period. The edtech market is fragmented owing to the presence of many global and regional companies. What is the projected size of the Edtech market in the next five years? Continue Reading Technavio has… Continue reading Edtech Market size to grow by USD 108.98 from 2022 to 2027 | The market is fragmented due to the presence of prominent companies like 2U Inc., Alphabet Inc., and Anthology Inc., many more

LG UNVEILS TRANSPARENT ANTENNA FOR VEHICLES WITH SAINT-GOBAIN SEKURIT AT CES 2024

Designed in Partnership with Global Leader in Glazing Solutions, LG’s Next-gen Transparent Antenna Delivers Seamless Design and Enhanced Telecommunications SEOUL, South Korea, Dec. 18, 2023 /PRNewswire/ — LG Electronics (LG) will unveil its transparent antenna for automobiles at CES 2024. LG’s transparent film-type antenna, which is applied directly to vehicle glass, was designed in collaboration with… Continue reading LG UNVEILS TRANSPARENT ANTENNA FOR VEHICLES WITH SAINT-GOBAIN SEKURIT AT CES 2024

Innovent Announces Publication of Mazdutide (IBI362) Phase 2 Full Results in Chinese Patients with Overweight or Obesity in Nature Communications

ROCKVILLE, Md. and SUZHOU, China, Dec. 17, 2023 /PRNewswire/ — Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and other major diseases, announces that results of a Phase 2 clinical trial of mazdutide (Innovent R&D code: IBI362), a glucagon-like peptide-1 receptor (GLP-1R)… Continue reading Innovent Announces Publication of Mazdutide (IBI362) Phase 2 Full Results in Chinese Patients with Overweight or Obesity in Nature Communications

Mediwave Unveils World’s First Mixed Reality & AI-Powered Connected Ambulance

SINGAPORE, Dec. 17, 2023 /PRNewswire/ — In a groundbreaking development, Mediwave, the digital healthcare arm of Wavenet, headquartered in Singapore, partners with 1990 Suwa Seriya, Sri Lanka’s national pre-hospital emergency ambulance service, to elevate life-enhancing emergency care through Mixed Reality and Artificial Intelligence (AI). Together, a fully Connected Ambulance, powered by Mediwave’s integrated Emergency Response… Continue reading Mediwave Unveils World’s First Mixed Reality & AI-Powered Connected Ambulance

Innovent Announces Publication of Mazdutide (IBI362) Phase 2 Full Results in Chinese Patients with Overweight or Obesity in Nature Communications

ROCKVILLE, Md. and SUZHOU, China, Dec. 17, 2023 /PRNewswire/ — Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and other major diseases, announces that results of a Phase 2 clinical trial of mazdutide (Innovent R&D code: IBI362), a glucagon-like peptide-1 receptor (GLP-1R)… Continue reading Innovent Announces Publication of Mazdutide (IBI362) Phase 2 Full Results in Chinese Patients with Overweight or Obesity in Nature Communications

EMA Recommends Arpraziquantel for Treatment of Schistosomiasis in Preschool-Aged Children

– Astellas contributed to the development of a pediatric formulation to treat schistosomiasis as a member of the Pediatric Praziquantel Consortium – TOKYO, Dec. 17, 2023 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) contributed to the development of a pediatric formulation to treat schistosomiasis as a member of the Pediatric Praziquantel Consortium… Continue reading EMA Recommends Arpraziquantel for Treatment of Schistosomiasis in Preschool-Aged Children

Sycuan entrega $180,000 a 25 organizaciones de beneficencia durante la ceremonia de entrega de regalos navideños de 2023

SAN DIEGO, 17 de diciembre de 2023  /PRNewswire-HISPANIC PR WIRE/ — El jueves 7 de diciembre, Sycuan Casino Resort entregó $180,000 a 25 organizaciones de beneficencia diversas durante su ceremonia de entrega de regalos navideños de 2023. Cada diciembre, los miembros del Consejo Tribal de Sycuan y la gerencia de Sycuan seleccionan individualmente a una… Continue reading Sycuan entrega $180,000 a 25 organizaciones de beneficencia durante la ceremonia de entrega de regalos navideños de 2023

Patriot Drills 56.6 m at 1.37% Li2O in Step-Out Hole and Completes Final Hole of 2023 Program at the CV5 Pegmatite, Quebec, Canada

VANCOUVER, BC, Dec. 17, 2023 /PRNewswire/ – December 18, 2023 – SYDNEY, Australia Highlights Continue Reading Figure 4: Remain to be drill tested corridor between the CV5 & CV13 spodumene pegmatites. (CNW Group/Patriot Battery Metals Inc) Figure 5: Drill holes completed through 2023 at CV13 Spodumene Pegmatite. (CNW Group/Patriot Battery Metals Inc) Table 2: Core… Continue reading Patriot Drills 56.6 m at 1.37% Li2O in Step-Out Hole and Completes Final Hole of 2023 Program at the CV5 Pegmatite, Quebec, Canada

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages ACELYRIN, INC. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SLRN

NEW YORK, Dec. 17, 2023 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ACELYRIN, INC. (NASDAQ: SLRN) between May 4, 2023 and September 11, 2023, both dates inclusive (the “Class Period”), of the important January 16, 2024 lead plaintiff deadline. SO WHAT: If you purchased ACELYRIN securities… Continue reading ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages ACELYRIN, INC. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SLRN

Illumina Announces Decision to Divest GRAIL

SAN DIEGO, Dec. 17, 2023 /PRNewswire/ — Today, Illumina, Inc. (NASDAQ: ILMN) announced that the company will divest GRAIL. The divestiture will be executed through a third-party sale or capital markets transaction, consistent with the European Commission’s divestiture order, with the goal of finalizing the terms by the end of the second quarter of 2024.… Continue reading Illumina Announces Decision to Divest GRAIL